Gottlieb, Alice B; Krueger, James G; Wittkowski, Knut et al. (2002) Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. Arch Dermatol 138:591-600
|
Krueger, James G (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46:1-23; quiz 23-6
|
Gottlieb, A; Krueger, J G; Bright, R et al. (2000) Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 42:428-35
|
Krueger, J G; Walters, I B; Miyazawa, M et al. (2000) Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis. J Am Acad Dermatol 43:448-58
|
Ferenczi, K; Burack, L; Pope, M et al. (2000) CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun 14:63-78
|
Gottlieb, A B; Lebwohl, M; Shirin, S et al. (2000) Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study. J Am Acad Dermatol 43:595-604
|
Ozawa, M; Ferenczi, K; Kikuchi, T et al. (1999) 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189:711-8
|
Coven, T R; Walters, I B; Cardinale, I et al. (1999) PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis. Photodermatol Photoimmunol Photomed 15:22-7
|
Walters, I B; Burack, L H; Coven, T R et al. (1999) Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 40:893-900
|
Trepicchio, W L; Ozawa, M; Walters, I B et al. (1999) Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest 104:1527-37
|
Showing the most recent 10 out of 15 publications